Eckert & Ziegler: Travel grant for young researchers in nuclear medicine
ECKERT & ZIEGLER Strahlen- und Medizintechnik AG / Miscellaneous
Announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.
Berlin, 19 February 2009. The Eckert & Ziegler/EANM abstract award is entering the second round. Up to 12th April 2009 young scientists can again participate in the competition with their innovative works in the field of nuclear medicine. Every year this travel grant is designed to support young scientists and doctoral students who seek to present the results of their work to larger audiences during the annual congress of the European Association of Nuclear Medicine (EANM) in October 2009. The five travel grants, each endowed with 1,000 EUR, will be offered by Eckert & Ziegler AG (ISIN DE0005659700), one of the leading European manufacturers of isotope products and the European Association of Nuclear Medicine (EANM). The award winners will be selected in cooperation with EANM. The five winners will receive their awards on 14th October 2009 during the EANM congress in Barcelona.
'In presenting the Eckert & Ziegler/EANM abstract award we wish to encourage young researchers to present their ideas to a wider audience and to collaborate more in exchanging ideas with other researchers engaged in the field of nuclear medicine. We hope that this will help to ensure that the enormous progress which has been made in medical imaging can soon be transformed into more precise, faster or cheaper methods of diagnosis and therapy', explained Dr Andreas Eckert, Chairman of the Board at Eckert & Ziegler.
The group sees considerable future potential in the further development of nuclear medical diagnostic techniques, especially based on the more widespread use of so-called hybrid cameras. These cameras combine different image processes - including Positron Emission Topography (PET). The quality and the information content of the images are taking on completely new dimensions and are enabling the development of new treatments and operational control processes.
Conditions for participation
All EANM members who are not older than 38 years of age at the time of application are entitled to participate. The applications can be submitted electronically via http://eanm09.eanm.org. Application deadline is 12th April 2009.
Eckert & Ziegler
The Eckert & Ziegler Group, that achieved a turnover of approx. 70 million EUR in 2008 with around 410 employees, is one of the world's largest providers of isotope component technology for radiation therapy and nuclear medicine. Eckert & Ziegler is supporting the greater use of hybrid systems by expanding its production sites for radioactive contrast agents and by developing automated synthesis modules in which scientists can produce new diagnostic substances with the requisite pharmaceutical quality.
Eckert & Ziegler AG, Karolin Riehle, Public Relations Robert-Rössle-Str. 10, D-13125 Berlin, Tel.: +49 (0) 30 / 941084-138, Fax-112, E-Mail: karolin.riehle@ezag.de, www.ezag.de
19.02.2009 Financial News transmitted by DGAP
Language: English
Issuer: ECKERT & ZIEGLER Strahlen- und Medizintechnik AG Robert-Rössle-Str. 10
13125 Berlin
Deutschland
Phone: +49 (0)30 941 084-0
Fax: +49 (0)30 941 084-112
E-mail: karolin.riehle@ezag.de
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Hamburg, Düsseldorf
End of News DGAP News-Service